According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), Major Depressive Disorder (MDD) is characterized by the presence of five or more specific symptoms during the same two-week period, representing a change from previous functioning. At least one of the symptoms must be either depressed mood or loss of interest or pleasure.
Diagnostic Criteria for Major Depressive Disorder:
- Depressed mood most of the day, nearly every day, as indicated by subjective report (e.g., feels sad, empty, hopeless) or observation made by others (e.g., appears tearful).
- Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day.
- Significant weight loss when not dieting, weight gain, or decrease or increase in appetite nearly every day.
- Insomnia or hypersomnia nearly every day.
- Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings of restlessness or being slowed down).
- Fatigue or loss of energy nearly every day.
- Feelings of worthlessness or excessive or inappropriate guilt nearly every day.
- Diminished ability to think or concentrate, or indecisiveness, nearly every day.
- Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.
Screening
The following two questions can be used to screen for depression
- ‘During the last month, have you often been bothered by feeling down, depressed or hopeless?’
- ‘During the last month, have you often been bothered by having little interest or pleasure in doing things?’
A ‘yes’ answer to either of the above should prompt a more in depth assessment.
Assessment:
Hospital Anxiety and Depression (HAD) scale and the Patient Health Questionnaire (PHQ-9).
- a score < 16 on the PHQ-9: less severe depression
- a score of ≥ 16 on the PHQ-9: severe depression
Management of less severe depression – no medication unless patient preference
Treatment options, listed in order of preference by NICE
- guided self-help
- group cognitive behavioural therapy (CBT)
- group behavioural activation (BA)
- lifestyle advice: exercise, healthy diet
Management of more severe depression: CBT+SSRI
- a combination of individual cognitive behavioural therapy (CBT) and an antidepressant
Medication:
- SSRIs are first-line medications in depression and are generally e.g. citalopram fluoxetine, or sertraline
- Fluoxetine – drug of choice in children and adolescents
- There is a lag period of 4 – 6 weeks before effects are seen
- Should be continued for at least 6 months following remission of symptoms
- Second-Line Treatment:
If there is an inadequate response to SSRIs, or if SSRIs are not suitable, other classes of antidepressants may be considered, such as:
-
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): e.g., venlafaxine, duloxetine.
- Mirtazapine: An antidepressant with a different mechanism of action, often considered when sedation is beneficial.
- Third-Line Treatment:
- Tricyclic Antidepressants (TCAs): e.g., amitriptyline, clomipramine. These may be considered if other treatments are ineffective, but they have a higher side-effect burden and are generally less well-tolerated.
- ECT should only be used as an acute treatment of severe depression that is and when a is required, or when .
life-threatening
rapid response
other treatments have failed
- Dose of antidepressant should be reduced (but not stopped) prior to ECT
LINK to ECT:
Electroconvulsive Therapy (ECT) is a medical treatment used primarily for severe mental health conditions, particularly when other treatments have been ineffective. It involves delivering controlled electrical currents to the brain to induce a brief seizure under general anesthesia.
Indications for ECT
ECT is used for:
- Severe Depression: Particularly with suicidal ideation, psychotic features, or when rapid response is needed.
- Treatment-Resistant Depression: When medication and psychotherapy have failed.
- Mania: Severe manic episodes in bipolar disorder.
- Schizophrenia: Catatonic or treatment-resistant cases.
- Catatonia: Marked psychomotor retardation or unresponsiveness.